Accurkardia

Accurkardia company information, Employees & Contact Information

Explore related pages

Related company profiles:

AccurKardia is an ECG-led diagnostics software company focused on transforming ECG data into a more powerful diagnostic tool and broad biomarker to improve patient outcomes and save lives globally. With initial applications in cardiology, the company offers transformative, cloud-based diagnostic tools, including AccurECG™, an FDA-cleared Class II software as a medical device (SaMD) for fully automated, near real-time ECG interpretation. AccurKardia’s AK+ Guard™—an AI-driven hyperkalemia detection solution using Lead I ECG data to help patients with conditions like CKD and ESRD identify life-threatening high potassium levels earlier—received FDA Breakthrough Device Designation and was accepted into the FDA Total Product Life Cycle (TAP) Advisory Program in December 2024. The company’s aortic stenosis detection model, AK-AVS™, received FDA Breakthrough Device Designation in October 2024. AccurKardia completed the 2024 Cohort of MedTech Innovator (MTI) and was one of five companies selected for the inaugural American Heart Association’s Heart and Brain Health Accelerator track within MTI.
Looking for a particular Accurkardia employee's phone or email?

Accurkardia Questions

News

AccurKardia Announces Clinical Pilot Study of Its AK+ Guard ECG-based, AI-powered Hyperkalemia Detection Software - Business Wire

AccurKardia Announces Clinical Pilot Study of Its AK+ Guard ECG-based, AI-powered Hyperkalemia Detection Software Business Wire

HeartBeam, AccurKardia Announce Strategic Collaboration - Diagnostic and Interventional Cardiology

HeartBeam, AccurKardia Announce Strategic Collaboration Diagnostic and Interventional Cardiology

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation - Business Wire

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation Business Wire

AccurKardia announces clinical pilot study of ECG-based, AI-powered hyperkalaemia detection software - Cardiac Rhythm News

AccurKardia announces clinical pilot study of ECG-based, AI-powered hyperkalaemia detection software Cardiac Rhythm News

HeartBeam, AccurKardia partner to speed up cardiac diagnosis - Mobi Health News

HeartBeam, AccurKardia partner to speed up cardiac diagnosis Mobi Health News

HeartBeam, AccurKardia partner on cardiac monitoring - MassDevice

HeartBeam, AccurKardia partner on cardiac monitoring MassDevice

AccurKardia AccurECG named "Best New Technology Solution for ECG" - Med-Tech Insights

AccurKardia AccurECG named "Best New Technology Solution for ECG" Med-Tech Insights

AccurKardia Delivers its ECG Interpretation Software Within the Lucem Health Reveal Family of Clinical AI Solutions - Diagnostic and Interventional Cardiology

AccurKardia Delivers its ECG Interpretation Software Within the Lucem Health Reveal Family of Clinical AI Solutions Diagnostic and Interventional Cardiology

Medical AI: AccurKardia Secures $2.7M for Clinical Grade ECG Analytics - HIT Consultant

Medical AI: AccurKardia Secures $2.7M for Clinical Grade ECG Analytics HIT Consultant

AccurKardia's automated ECG analysis software snags FDA nod - Fierce Biotech

AccurKardia's automated ECG analysis software snags FDA nod Fierce Biotech

AccurKardia wins FDA breakthrough nod for ECG-based AI screening software - MassDevice

AccurKardia wins FDA breakthrough nod for ECG-based AI screening software MassDevice

AccurKardia Receives FDA Breakthrough Device Designation for First-of-its-Kind Aortic Valve Stenosis ECG-based AI Screening Software - Business Wire

AccurKardia Receives FDA Breakthrough Device Designation for First-of-its-Kind Aortic Valve Stenosis ECG-based AI Screening Software Business Wire

AccurKardia’s AccurECG Named “Best New Technology Solution for ECG” in 9 - Business Wire

AccurKardia’s AccurECG Named “Best New Technology Solution for ECG” in 9 Business Wire

FDA clears ECG interpretation software from AccurKardia - MassDevice

FDA clears ECG interpretation software from AccurKardia MassDevice

AccurKardia Receives FDA Breakthrough Device Designation for AI-powered Hyperkalemia Detection Solution Using Lead I ECG Data - Business Wire

AccurKardia Receives FDA Breakthrough Device Designation for AI-powered Hyperkalemia Detection Solution Using Lead I ECG Data Business Wire

AccurKardia Announces Final Closing of $2.7 Million Series Seed Round - Business Wire

AccurKardia Announces Final Closing of $2.7 Million Series Seed Round Business Wire

AccurKardia Delivers Its ECG Interpretation Software Within the Lucem Health Reveal Family of Clinical AI Solutions - Business Wire

AccurKardia Delivers Its ECG Interpretation Software Within the Lucem Health Reveal Family of Clinical AI Solutions Business Wire

AccurKardia’s AccurECG™ Analysis System Receives FDA 510(k) Clearance - Business Wire

AccurKardia’s AccurECG™ Analysis System Receives FDA 510(k) Clearance Business Wire

Top Accurkardia Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant